RESUMO
In order to delineate individual pathomechanisms in acute lung injury and pulmonary toxicology, we developed a primary coculture system to simulate the human alveolo-capillary barrier. Human pulmonary microvascular endothelial cells (HPMEC) were cocultivated with primary isolated human type II alveolar epithelial cells (HATII) on opposite sides of a permeable filter support, thereby constituting a bilayer. Within 7-11 days of coculture, the HATII cells partly transdifferentiated to type-I-like (HATI-like) cells, as demonstrated by morphological changes from a cuboidal to a flattened morphology, the loss of HATII-cell-specific organelles and the increase of HATI-cell-related markers (caveolin-1, aquaporin-5, receptor for advanced glycation end-products). Immunofluorescent analysis detected type-II-like and type-I-like alveolar epithelial cells mimicking the heterocellular composition of alveolar epithelium in vivo. The heterocellular epithelial monolayer showed a circumferential staining of tight-junctional (ZO-1, occludin) and adherens-junctional (E-cadherin, beta-catenin) proteins. HPMEC on the opposite side also developed tight and adherens junctions (VE-cadherin, beta-catenin). Under integral barrier properties, exposure to the proinflammatory cytokine tumour necrosis factor-alpha from either the endothelial (basolateral) or the epithelial (apical) side caused a largely compartmentalized release of the chemokines interleukin-8 and monocyte chemoattractant protein-1. Thus, the established coculture provides a suitable in vitro model to examine barrier function at the distal lung, including the interaction of microvascular endothelial cells with ATII-like and ATI-like epithelial cells. The compartmentalization of the barrier-forming bilayer also allows mechanisms of lung injury to be studied in both the epithelial (intra-alveolar) and the endothelial (intravascular) compartments.
Assuntos
Lesão Pulmonar Aguda/etiologia , Barreira Alveolocapilar/citologia , Endotélio Vascular/citologia , Alvéolos Pulmonares/citologia , Lesão Pulmonar Aguda/patologia , Aquaporina 5/genética , Aquaporina 5/metabolismo , Barreira Alveolocapilar/fisiologia , Técnicas de Cultura de Células , Diferenciação Celular/genética , Diferenciação Celular/fisiologia , Técnicas de Cocultura , Endotélio Vascular/metabolismo , Endotélio Vascular/fisiologia , Células Epiteliais/citologia , Células Epiteliais/metabolismo , Células Epiteliais/fisiologia , Regulação da Expressão Gênica , Humanos , Potenciais da Membrana/fisiologia , Microscopia Eletrônica de Transmissão , Modelos Biológicos , Alvéolos Pulmonares/metabolismo , Alvéolos Pulmonares/fisiologia , Artéria Pulmonar/citologia , Proteína C Associada a Surfactante Pulmonar/genética , Proteína C Associada a Surfactante Pulmonar/metabolismo , Receptor para Produtos Finais de Glicação Avançada/genética , Receptor para Produtos Finais de Glicação Avançada/metabolismoRESUMO
Airway epithelial cells provide a barrier to the translocation of inhaled materials. Tight (TJ) and adherens junctions (AJ) play a key role in maintaining barrier functions, and are responsible for the selective transport of various substances through the paracellular pathway. In this study we compared a bronchial cell line (16HBE14o-) and primary bronchial cells (HBEC), both cocultivated with the fibroblast cell line Wi-38, with respect to their structural differentiation and their reaction to cytokine stimulation. HBEC formed a pseudostratified epithelial layer and expressed TJ and AJ proteins after 2 weeks in coculture. Mucus-producing and ciliated cells were found within 24 days. Additionally, a beating activity of the ciliated HBEC (14-19Hz) could be detected. 16HBE14o- in coculture showed a multilayered growth without differentiation to a pseudostratified airway epithelium. Simultaneous exposure to TNF-alpha- and IFN-gamma-induced significant changes in barrier function and paracellular permeability in the cocultures of HBEC/Wi-38 but not in the 16HBE14o-/Wi-38. In summary, HBEC in coculture mimic the structure of native polarized bronchial epithelium showing basal, mucus-producing and ciliated cells. Our system provides an opportunity to examine the factors that influence barrier and mucociliary function of bronchial epithelium within a time frame of 3 weeks up to 3 months in an in vivo-like differentiated model.
Assuntos
Brônquios/citologia , Modelos Biológicos , Junções Aderentes/efeitos dos fármacos , Western Blotting , Brônquios/ultraestrutura , Técnicas de Cultura de Células , Técnicas de Cocultura , Células Epiteliais/citologia , Células Epiteliais/ultraestrutura , Humanos , Imuno-Histoquímica , Interferon gama/administração & dosagem , Interferon gama/farmacologia , Microscopia Eletrônica de Varredura , Microscopia Eletrônica de Transmissão , Junções Íntimas/efeitos dos fármacos , Fator de Necrose Tumoral alfa/administração & dosagem , Fator de Necrose Tumoral alfa/farmacologiaRESUMO
The transporter associated with antigen processing (TAP) gene products is involved in the processing of endogenous peptides that bind to MHC class I molecules. Mutations and/or polymorphism within these genes could alter the efficacy of the immune response which might be relevant for the development of autoimmune diseases and cancer. In this study we examined both the structural integrity and the polymorphism of TAP2 in renal cell carcinoma lesions by sequencing TAP2 in renal cell carcinoma lesions and autologous normal kidney epithelium. TAP2 sequence analysis of 31 renal cell carcinoma lesions, one oncocytoma and respective autologous normal kidney epithelium revealed no mutation in the TAP2 gene, whereas a TAP2 polymorphism was detected at position -36 up-stream of the ATG. This polymorphism is heterozygous in about 66% of the lesions analyzed. In addition, heterozygosity at base pair position 1797 downstream of the ATG was found, which did not affect the amino acid composition. The distribution of the TAP2 alleles analyzed in the different lesions demonstrated a 48.4% homozygosity of the tumors regarding different N-SNPs. Most of the known S-SNPs showed 61.3% heterozygosity independent of a particular allele. Thus, TAP2 gene polymorphism is not linked to renal cell carcinoma since no association between a particular amino acid residue and the disease was found.
Assuntos
Transportadores de Cassetes de Ligação de ATP/genética , Carcinoma de Células Renais/genética , Neoplasias Renais/genética , Membro 3 da Subfamília B de Transportadores de Cassetes de Ligação de ATP , Idoso , Idoso de 80 Anos ou mais , Alelos , DNA/química , Enzimas de Restrição do DNA/farmacologia , Epitélio/metabolismo , Feminino , Heterozigoto , Homozigoto , Humanos , Rim/citologia , Masculino , Pessoa de Meia-Idade , Mutação , Peptídeos/química , Polimorfismo Genético , RNA/química , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
The HLA class I antigen-processing machinery (APM) plays a crucial role in the generation of peptides from endogenously synthesized proteins and in their presentation to cytotoxic T lymphocytes. The potential role of defects of APM components in immune escape mechanisms used by malignant cells has prompted us to analyze their expression in renal cell carcinoma (RCC) lesions with special emphasis on TAP because of its critical role in the loading of HLA class I antigens with peptides. Immunohistochemical staining of 51 formalin-fixed RCC lesions and autologous normal renal epithelium detected transporter associated with antigen processing (TAP)1 and tapasin deficiencies in 63 and 80% of the tumor lesions. Impaired low molecular weight protein (LMP)2 and LMP7 expression was found in 73 and 33% of the RCC lesions analyzed, respectively. In contrast to the high frequency of APM component down-regulation, HLA class I heavy chain and beta(2)-microglobulin defects were detected in only 12 and 10% of the lesions, respectively. Concomitant TAP1 and LMP2 deficiencies were found in approximately 57% of RCC lesions, whereas a coordinated down-regulation of all APM components occurred only in 5% of the tumor specimens analyzed. The presence of APM defects was independent of tumor stage and grade but varied significantly among the RCC subtypes. TAP abnormalities do not appear to be attributable to structural alterations because no mutations in TAP1 were detected in TAP1-deficient RCC lesions. These data suggest that TAP defects in RCC lesions are caused by regulatory abnormalities. Therefore, T-cell-based immunotherapy may benefit from the administration of cytokines that up-regulate TAP expression.
Assuntos
Apresentação de Antígeno , Carcinoma Papilar/metabolismo , Carcinoma de Células Renais/metabolismo , Antígenos de Histocompatibilidade Classe I/metabolismo , Neoplasias Renais/metabolismo , Complexos Multienzimáticos , Membro 2 da Subfamília B de Transportadores de Cassetes de Ligação de ATP , Membro 3 da Subfamília B de Transportadores de Cassetes de Ligação de ATP , Transportadores de Cassetes de Ligação de ATP/genética , Transportadores de Cassetes de Ligação de ATP/metabolismo , Carcinoma Papilar/patologia , Carcinoma de Células Renais/patologia , Cisteína Endopeptidases/metabolismo , Regulação para Baixo , Humanos , Rim/metabolismo , Neoplasias Renais/patologia , Linfócitos do Interstício Tumoral/metabolismo , Complexo de Endopeptidases do Proteassoma , Microglobulina beta-2/metabolismoRESUMO
We report here on 2 patients who received adjuvant vaccination with an HLA-A2- or HLA-A24-restricted tyrosinase peptide, respectively, and GM-CSF for frequently relapsing stage IV melanoma. Following resection of metastases and irradiation of brain metastases in 1 patient, both patients were without evidence of disease when receiving the first vaccination. While the patients had had 9 and 12, respectively, mostly s.c., relapses during the 3 years before vaccination, they experienced freedom from relapse for more than 2 years after vaccination. We found a T-cell response to the vaccine peptide in both patients in the peripheral blood by ex vivo IFN-gamma ELISPOT assay. The T-cell population could be further characterized by 4-color flow cytometry in 1 patient, showing that the majority of the peptide-specific CD3(+)CD8(+)IFN-gamma(+) T cells were granzyme B-positive and CCR-7-negative, characterizing them as effector T cells with the ability to mediate cytotoxicity and migrate to inflamed tissues. In this patient also, augmentation of the T-cell response to autologous tumor cells by vaccination could be detected. A single-site postvaccination relapse occurred in both patients, showing downregulation of tyrosinase expression in 1 patient, while normal expression levels for tyrosinase, MHC class I antigens and components of the antigen-processing machinery were found in the other patient. These results suggest that peptide vaccination resulted in a prolonged relapse-free interval in these high-risk patients.
Assuntos
Vacinas Anticâncer , Melanoma/diagnóstico , Melanoma/prevenção & controle , Monofenol Mono-Oxigenase/uso terapêutico , Neoplasias Encefálicas/prevenção & controle , Neoplasias Encefálicas/secundário , Complexo CD3/biossíntese , Antígenos CD8/biossíntese , Intervalo Livre de Doença , Epitopos , Citometria de Fluxo , Humanos , Imuno-Histoquímica , Interferon gama/biossíntese , Interferon gama/metabolismo , Melanoma/patologia , Metástase Neoplásica , Peptídeos/química , Peptídeos/uso terapêutico , Reação em Cadeia da Polimerase , RNA Mensageiro/metabolismo , Recidiva , Linfócitos T/metabolismo , Fatores de TempoRESUMO
The Tap1 and Tap2 genes encoding for a heterodimeric peptide transporter play a key role in antigen processing and presentation. The TAP complex mediates the transport of peptides generated by the IFN-gamma-inducible proteasome subunits LMP2, 7 and 10 from the cytosol into the endoplasmic reticulum (ER), where they bind to MHC class I molecules. In contrast to the frequent polymorphisms within the rat Tap genes which exert functional differences, polymorphic regions within the human Tap genes have been demonstrated, but not systematically analyzed in terms of their functional significance. Both the Tap1 and Lmp2 genes are transcribed from a bidirectional intergenic promoter which is regulated by at least three sequences located in the Tap1 proximal region. We describe here a polymorphic site in the shared TAP1/LMP2 promoter which frequently occurred in human tumor cells of distinct origin. This polymorphism resulted in a Gright curved arrow T substitution 151 bp upstream of the translation start of Tap1. Using transient transfection assays with luciferase reporter constructs, the transcriptional activities of the different allelic variants of the TAP1/LMP2 promoter were comparable suggesting no functional consequences of this TAP1/LMP2 promoter polymorphism.